Epsilon M&A Deal Report - Mepha Pharma
Transaction Multiples for the Valuation of Private Companies
Cephalon / Mepha Pharma
No EMAT :
25634
Announced Date :
31/01/2010
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Cephalon
Target :
Mepha Pharma
Country :
Switzerland
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 1989, Mepha Pharma manufactures and markets branded and non-branded pharmaceutical generics as well as specialty products. The company has a specific expertise in innovative dosage...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 31/05/2011 | Bastide Le Confort Medical (BLCM) | A a Z Sante | France | * | 25598 |
| 04/08/2011 | Mears Group | Supported Living Division of Choices (Holdings) | United Kingdom | ** | 25568 |
Source: Epsilon Research / EMAT
